📣 VC round data is live. Check it out!

Wacker Chemie Valuation Multiples

Discover Wacker Chemie's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Luberef, UPL, Croda International, SOL and more.

Wacker Chemie Overview

About Wacker Chemie

Wacker Chemie AG manufactures and sells chemicals and silicon-based products. The firm organizes itself into four segments based on product type. The Wacker Silicones segment, which generates the majority revenue of any segment, sells silicon- and methanol-based products, including durable insulators, lubricants, and sealants. The Wacker Polymers segment provides chemical binders and additives used in construction industry products. The Wacker Biosolutions segment sells chemicals to the pharmaceutical and agrochemical industries. The Wacker Polysilicon segment sells material for solar power and semiconductors. The majority of revenue comes from Europe, China, India, and South Korea.


Founded

1914

HQ

Germany

Employees

16.6K

Website

wacker.com

Sectors

Financials (LTM)

Revenue: $7B
EBITDA: $605M

EV

$7B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Wacker Chemie Financials

Wacker Chemie reported last 12-month revenue of $7B and EBITDA of $605M.

In the same LTM period, Wacker Chemie generated $922M in gross profit, $605M in EBITDA, and had net loss of ($525M).

Revenue (LTM)


Wacker Chemie P&L

In the most recent fiscal year, Wacker Chemie reported revenue of $6B and EBITDA of $497M.

Wacker Chemie is unprofitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 8%, and net margin of (15%).

See analyst estimates for Wacker Chemie
LTMLast FY202320242025202620272028
Revenue$7B$6B$7B$7B$6B
Gross Profit$922M$766M$1B$1B$766M
Gross Margin14%12%17%17%12%
EBITDA$605M$497M$1B$940M$139M
EBITDA Margin9%8%14%14%2%
EBIT Margin(0%)(2%)5%5%(2%)
Net Profit($525M)($937M)$365M$281M($956M)
Net Margin(8%)(15%)5%4%(15%)
Net Debt-$1B---

Financial data powered by Morningstar, Inc.

Wacker Chemie Stock Performance

Wacker Chemie has current market cap of $6B, and enterprise value of $7B.

Market Cap Evolution


Wacker Chemie's stock price is $115.67.

Wacker Chemie share price decreased by 0.1% in the last 30 days, and increased by 61.7% in the last year.

Wacker Chemie has an EPS (earnings per share) of $-18.86.

See more trading valuation data for Wacker Chemie
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$7B$6B-0.1%-0.1%16.5%61.7%$-18.86

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Wacker Chemie Valuation Multiples

Wacker Chemie trades at 1.0x EV/Revenue multiple, and 11.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Wacker Chemie

EV / Revenue (LTM)


Wacker Chemie Financial Valuation Multiples

As of June 2, 2026, Wacker Chemie has market cap of $6B and EV of $7B.

Wacker Chemie has a P/E ratio of (10.9x).

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.1x0.9x1.0x1.1x
EV/EBITDA11.2x13.6x6.6x7.2x48.6x
EV/EBITn/m(66.8x)17.5x21.5x(66.8x)
EV/Gross Profit7.3x8.8x5.4x5.9x8.8x
P/E(10.9x)(6.1x)15.7x20.5x(6.0x)
EV/FCFn/mn/m19.5x(17.0x)n/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Wacker Chemie Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Wacker Chemie Margins & Growth Rates

Wacker Chemie grew revenue by 4% and EBITDA by 52% in the last fiscal year.

In the most recent fiscal year, Wacker Chemie reported gross margin of 12%, EBITDA margin of 8%, and net margin of (15%).

See estimated margins and future growth rates for Wacker Chemie

Wacker Chemie Margins

Last FY202420252026202720282029
Gross Margin12%17%12%16%
EBITDA Margin8%14%2%11%
EBIT Margin(2%)5%(2%)3%
Net Margin(15%)4%(15%)1%
FCF Margin(0%)(6%)(0%)3%

Wacker Chemie Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%(11%)(4%)4%
Gross Profit Growth41%(9%)(33%)41%
EBITDA Growth52%(8%)(85%)442%
EBIT Growth(267%)(19%)(132%)(267%)
Net Profit Growth(105%)(23%)(441%)(105%)
FCF Growth(1646%)(215%)(97%)(1646%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Wacker Chemie Operational KPIs

Wacker Chemie's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Wacker Chemie's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Wacker Chemie's Rule of X is 22% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Wacker Chemie
LTMLast FY202320242025202620272028
Rule of 4013%16%---
Bessemer Rule of X19%22%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue6%6%5%6%6%
G&A Expenses to Revenue3%4%3%4%4%
R&D Expenses to Revenue4%4%3%4%4%
Opex to Revenue-14%12%13%14%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Wacker Chemie Competitors

Wacker Chemie competitors include Luberef, UPL, Croda International, SOL, Fuchs, Celanese, IMCD, Sumitomo Chemical, Arkema and Dottikon ES Holding.

Most Wacker Chemie public comparables operate across Chemicals.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Luberef2.6x2.3x17.9x14.0x
UPL1.4x1.3x7.2x7.2x
Croda International2.7x2.7x11.5x11.3x
SOL3.1x3.0x12.2x11.7x
Fuchs1.4x1.3x8.9x8.9x
Celanese1.8x1.8x9.1x8.6x
IMCD1.4x1.4x12.3x12.1x
Sumitomo Chemical0.7x0.8x8.9x6.6x

This data is available for Pro users. Sign up to see all Wacker Chemie competitors and their valuation data.

Start Free Trial

Acquisitions by Wacker Chemie

Wacker Chemie has acquired 2 companies to date.

Last acquisition by Wacker Chemie was on May 8th 2023. Wacker Chemie acquired ADL Biopharma for $110M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Wacker Chemie

ADL Biopharma
Genopis
Description
ADL Biopharma is a León-based contract development and manufacturing organization in Spain focused on precision fermentation and synthesis of oral and sterile antibiotics. It operates one of Europe's largest industrial fermentation facilities, spanning 20,000 square meters, with capacities up to 100,000 liters per batch. The company conducts upstream and downstream processes for biologics like enzymes and probiotics, alongside API production for beta-lactams. ADL Biopharma supplies pharmaceutical firms such as Antibióticos S.A. and leverages a pilot plant for scaling novel molecules. With over 50 years of expertise since 1967, it benefits from León's biotech cluster and temperate climate.
Genopis is a Seongnam-headquartered contract development and manufacturing organization focused on plasmid DNA technologies for gene therapies, cell therapies, and mRNA vaccines. The company delivers end-to-end services from plasmid design and process development to cGMP manufacturing at scales ranging from milligrams for preclinical studies to kilograms for commercial production. Genopis operates advanced facilities in South Korea equipped for high-quality plasmid purification and analytics, supporting global biotech firms in accelerating clinical trials and market entry. Its expertise includes supercoiled plasmid production and endotoxin-free processes tailored for human applications.
HQ CountryNicaraguaUnited States
HQ City
León
San Diego, CA
Deal Date8 May 20233 Feb 2021
Valuation$110M$39M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Wacker Chemie acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Wacker Chemie

Wacker Chemie has invested in 1 company to date.

Latest investment by Wacker Chemie was on June 28th 2016. Wacker Chemie invested in 1366 Technologies in their $15M Series D round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Wacker Chemie

1366 Technologies
Description
1366 Technologies is a Bedford-headquartered manufacturer of low-cost silicon wafers for photovoltaic solar cells. The company's Direct Wafer process reduces production costs by 50 percent, compatible with existing module lines. Founded in 2008, 1366 Tech shipped over 100 megawatts of wafers before its 2020 acquisition by a strategic buyer, advancing U.S. solar manufacturing.
HQ CountryUnited States
HQ City
-
Deal Date28 Jun 2016
RoundSeries D
Raised$15M
InvestorsWacker Chemie
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Wacker Chemie investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Wacker Chemie

When was Wacker Chemie founded?Wacker Chemie was founded in 1914.
Where is Wacker Chemie headquartered?Wacker Chemie is headquartered in Germany.
How many employees does Wacker Chemie have?As of today, Wacker Chemie has over 16K employees.
Is Wacker Chemie publicly listed?Yes, Wacker Chemie is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Wacker Chemie?Wacker Chemie trades under WCH ticker.
When did Wacker Chemie go public?Wacker Chemie went public in 2006.
Who are competitors of Wacker Chemie?Wacker Chemie main competitors include Luberef, UPL, Croda International, SOL, Fuchs, Celanese, IMCD, Sumitomo Chemical, Arkema, Dottikon ES Holding.
What is the current market cap of Wacker Chemie?Wacker Chemie's current market cap is $6B.
What is the current revenue of Wacker Chemie?Wacker Chemie's last 12 months revenue is $7B.
What is the current revenue growth of Wacker Chemie?Wacker Chemie revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Wacker Chemie?Current revenue multiple of Wacker Chemie is 1.0x.
What is the current EBITDA of Wacker Chemie?Wacker Chemie's last 12 months EBITDA is $605M.
What is Wacker Chemie's EBITDA margin?Wacker Chemie's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Wacker Chemie?Current EBITDA multiple of Wacker Chemie is 11.2x.
What is the current FCF of Wacker Chemie?Wacker Chemie's last 12 months FCF is $2M.
What is Wacker Chemie's FCF margin?Wacker Chemie's last 12 months FCF margin is 0%.
What is the current EV/FCF multiple of Wacker Chemie?Current FCF multiple of Wacker Chemie is 2938.5x.
How many companies Wacker Chemie has acquired to date?As of June 2026, Wacker Chemie has acquired 2 companies.
What was the largest acquisition by Wacker Chemie?$110M acquisition of ADL Biopharma on 8th May 2023 was the largest M&A Wacker Chemie has done to date.
What companies Wacker Chemie acquired?Wacker Chemie acquired ADL Biopharma and Genopis.
In how many companies Wacker Chemie has invested to date?As of June 2026, Wacker Chemie has invested in 1 company.
What was the last Wacker Chemie investment?On 28th June 2016 Wacker Chemie invested in 1366 Technologies, participating in a $15M Series D round.
In what companies Wacker Chemie invested in?Wacker Chemie invested in 1366 Technologies.

See public comps similar to Wacker Chemie

Lists including Wacker Chemie

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial